Shiseido's core profit nearly doubles in H1 as the Americas turn a profit

Shiseido's core operating profit rose 90.1% to ¥44.4bn in the six months to June, the Japanese beauty group said in results released on 5 August, as years of restructuring in its long-lossmaking Americas business began converting into profit and cost discipline pushed the group's margin up sharply even as underlying sales barely moved.

Net sales rose 6.2% to ¥499.0bn, Shiseido said, though the increase was almost entirely a currency effect: stripping out exchange-rate swings and the impact of past business disposals, sales were roughly flat on the year, with a weak first quarter (down 3% on that basis) offset by a return to growth in the second (up 2%). Core operating margin, meanwhile, jumped to 8.9% from 5.0%, and net profit more than tripled to ¥29.7bn, as the company applied cost management it described as company-wide on top of the structural reform already under way.

Japan's margin climbs as inbound cools

In its home market, Shiseido reported Japan sales of ¥144.7bn, down 0.8% on the year, but core operating profit rose 7.2% to ¥20.9bn and the core operating margin improved to 14.4% from 13.3%, a gain of 1.1 percentage points. The company attributed the improvement to lower cost and personnel ratios alongside stronger marketing spend, and pointed to Elixir and the SHISEIDO brand's success in attracting new customers as domestic drivers even as sales tied to foreign visitors fell by a mid-teens percentage — a decline the company said was narrowing as its Japan business diversifies its inbound customer base beyond China toward Thailand, Taiwan and South Korea.

Americas turns a profit, Europe lags

The clearer turnaround was in the Americas, where core operating profit swung to ¥2.0bn from a ¥5.8bn loss a year earlier, lifting the regional margin by 14.3 percentage points to 3.6%. The company credited restructuring effects and cost cuts shared with its European operation — including consolidated purchasing and shared content production — and said it is targeting a full-year profit in the Americas for 2026. China and travel retail remained the group's largest profit contributor, with sales up 10.0% to ¥191.4bn and core operating profit up 22.7% to ¥47.6bn on a strong showing in China's mid-year "618" shopping festival, lifting the segment's margin to 24.6%. Europe was the lone region to move the wrong way: its operating loss widened slightly to ¥3.4bn as the company front-loaded marketing spend on new fragrance launches, a gap it said it expects to close in the second half.

Shiseido left its full-year guidance unchanged, saying it still aims to beat its core operating profit plan even as it flagged a risk that group sales, particularly in the US and Europe, could fall short of target.

The gap between the two headline numbers is the story here. A 90% jump in core operating profit against sales that were essentially flat in real terms is a restructuring result, not a demand one — the company is proving it can run the group leaner, not yet that it can grow it faster. That distinction matters for the second half, when Shiseido is banking on a heavier new-product slate, including a reformulated Elixir cream and new MaxMara fragrances, to do what cost-cutting alone cannot: turn the flat top line into real growth.